companydata.dkFamilien Andresens selskab til fremme af medicinsk forskning A/S: Financial statements 2025
CVR: 39694395
Familien Andresens selskab til fremme af medicinsk forskning A/S (CVR 39694395) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -25,521,250 and a net result of DKK -19,380,900 compared with DKK -6,685,198 the year before. Equity amounted to DKK 86,296. The solvency ratio was 0.5%.
- Gross Profit
- -25,521,250 kr.
- Profit/Loss
- -19,380,900 kr.
- Equity
- 86,296 kr.
- Total Assets
- 16,111,296 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -25.5 mio. | -19.4 mio. | 86 t. | 0 |
| 2024 | - | -9.5 mio. | -6.7 mio. | 19.5 mio. | 1 |
| 2023 | - | -7.5 mio. | -4.9 mio. | 26.2 mio. | 1 |
| 2022 | - | -7.5 mio. | -4.8 mio. | 31.1 mio. | 0 |
| 2021 | - | -7.5 mio. | -4.6 mio. | 35.9 mio. | 0 |
Find more companies like Familien Andresens selskab til fremme af medicinsk forskning A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Familien Andresens selskab til fremme af medicinsk forskning A/S has published its annual report for 2024. Gross profit came to DKK -9,518,750, and the net result was DKK -6,685,198.
About Familien Andresens selskab til fremme af medicinsk forskning A/S
Familien Andresens selskab til fremme af medicinsk forskning A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 2018. The company is registered under the industry Investering for egen regning. The management consists of Jørgen Jacobsen. The company is owned by CALLIE INVEST A/S. In 2025, the company reported a gross profit of DKK -25,521,250 and a net result of DKK -19,380,900 compared with DKK -6,685,198 the year before. Equity amounted to DKK 86,296.